SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Merck
MRK 97.80+3.0%Nov 21 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: EepOpp who wrote (524)2/20/1998 11:56:00 PM
From: Sunny Chu  Read Replies (1) of 1580
 
To give you some insight, Merck is a company that will not work on a drug that has less then 300 million in sales per year. They are very picky as to what they develop. Aside from that, they spend probably the most money in R&D in this industry. Secondly, try looking in their history of drugs. I don't think that you are going to find much problems there. Thirdly, Merck is a company that tries to develop their own drugs rather than collaborate with other companies and pay them a royalty. Hope this insight can be of help to you.

Sunny
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext